Does DEGARELIX Cause Injection site induration? 91 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Injection site induration have been filed in association with DEGARELIX (FIRMAGON). This represents 2.4% of all adverse event reports for DEGARELIX.
91
Reports of Injection site induration with DEGARELIX
2.4%
of all DEGARELIX reports
1
Deaths
19
Hospitalizations
How Dangerous Is Injection site induration From DEGARELIX?
Of the 91 reports, 1 (1.1%) resulted in death, 19 (20.9%) required hospitalization, and 1 (1.1%) were considered life-threatening.
Is Injection site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 91 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
What Other Drugs Cause Injection site induration?
ETANERCEPT (1,451)
NALTREXONE (866)
ADALIMUMAB (577)
GLATIRAMER (382)
DUPILUMAB (376)
INTERFERON BETA-1A (254)
EVOLOCUMAB (229)
ENBREL (218)
LEUPROLIDE (207)
IXEKIZUMAB (177)
Which DEGARELIX Alternatives Have Lower Injection site induration Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM